Active, not recruitingPhase 2NCT06171217

Realizing Effectiveness Across Continents With Hydroxyurea

Studying Genetic hemoglobinopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Russell Ware, MD, PhD
Children's Hospital Medical Center, Cincinnati
Intervention
Hydroxyurea(drug)
Enrollment
811 enrolled
Eligibility
3-10 years · All sexes
Timeline
20232033

Study locations (4)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06171217 on ClinicalTrials.gov

Other trials for Genetic hemoglobinopathy

Additional recruiting or active studies for the same condition.

See all trials for Genetic hemoglobinopathy

← Back to all trials